EMC
56
8
CB
58
3
PX
62
3
KLAC
59
2
AN
46
2
SYF
81
7
PSX
49
2
ICE
55
2
PRU
70
8
L
58
7
AVY
50
3
STT
37
4
XOM
60
4
MLM
37
2
HIG
70
4
EA
41
3
GM
65
7
GT
46
5
TROW
34
7
PFE
21
3
EMC
56
8
CB
58
3
PX
62
3
KLAC
59
2
AN
46
2
SYF
81
7
PSX
49
2
ICE
55
2
PRU
70
8
L
58
7
AVY
50
3
STT
37
4
XOM
60
4
MLM
37
2
HIG
70
4
EA
41
3
GM
65
7
GT
46
5
TROW
34
7
PFE
21
3
Financhill
Back

Vigil Neuroscience Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
27

VIGL
Vigil Neuroscience

Last Price:
3.43
Seasonality Move:
0.04%
Sell
42

NBY
NovaBay Pharmaceuticals

Last Price:
0.71
Seasonality Move:
-19.92%
Sell
27
Vigil Neuroscience (VIGL) is a Sell

Is Vigil Neuroscience a Buy, Sell or Hold?

  • The current Vigil Neuroscience [VIGL] share price is $3.44. The Score for VIGL is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • VIGL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VIGL Stock Price Chart

What is Vigil Neuroscience's stock price today?

  • The Vigil Neuroscience share price today is $3.44
    The current trend is relatively stagnant and VIGL is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

VIGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 50.2 Buy
Chaikin Money Flow: -37867 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.27 - 3.63) Sell
Bollinger Bands (100): (3.25 - 4.17) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 55.73 Buy
Chaikin Money Flow: -66635 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.46 - 0.7) Buy
Bollinger Bands (100): (0.33 - 3.11) Sell

VIGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.34 Buy
20-day SMA: 3.44 Buy
50-day SMA: 3.53 Sell
200-day SMA: 3.43 Buy
8-day EMA: 3.37 Buy
20-day EMA: 3.4 Buy
50-day EMA: 3.52 Sell
200-day EMA: 4 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.71 Buy
20-day SMA: 0.61 Buy
50-day SMA: 0.55 Buy
200-day SMA: 3.29 Sell
8-day EMA: 0.7 Buy
20-day EMA: 0.65 Buy
50-day EMA: 0.87 Sell
200-day EMA: 7.55 Sell

Vigil Neuroscience Earnings Growth & VIGL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.01 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Vigil Neuroscience Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):